Abstract:Introduction/Background: Deep neural networks have shown great promise in advancing drug discovery and precision medicine. By leveraging large amounts of complex biomedical and chemical data, deep learning approaches can identify novel targets, predict drug-target and drug-drug interactions, generate new molecular structures, and assist in personalized treatment selection and development. However, fully utilizing deep learning techniques for optimization across the drug development pipeline remains an ongoing challenge. Materials and Methods: A comprehensive literature review was conducted using major bibliographic databases including PubMed, Web of Science, and Scopus. Search terms included combinations of "deep learning", "drug discovery", "precision medicine", "biomedical data", and "neural networks". Over 200 papers published between 2010-2023 related to deep learning applications in pharmacology and genomics were identified and reviewed. Results: Deep learning has been widely applied at various stages of the drug discovery process including target identification/prioritization, lead generation/optimization, and prediction of molecular properties. Convolutional neural networks are commonly used for the representation and classification of biological sequence and image data for tasks such as gene expression analysis and pathogen detection from microscopy images. Graph neural networks effectively model compound structures and interactome networks to predict molecular bindings and disease associations. Multi-modal neural networks integrate diverse data types for personalized treatment response prediction and biomarker discovery. Challenges remain around data and model interpretation, generalization to new targets/diseases, and integration across domains. Discussion: While deep learning has shown promise, rigorous benchmarking and validation on real-world clinical endpoints are still needed to establish usefulness in decision-making. Data and model transparency must be improved to enable scientific insights. Privacy and security risks accompanying "real world" biomedical big data will require ethical practices. Standardization and sharing of resources/protocols could accelerate progress by enabling comparison of techniques. Combining deep learning with other AI paradigms like causal inference may further improve utility in drug discovery and precision healthcare. Conclusion: Deep neural networks demonstrate potential for optimizing drug development and precision medicine applications. Continued advancement relies on addressing challenges around data, models, validation, and ethics. Multi-disciplinary collaborations integrating machine learning, molecular biology, medicine, and other domains are needed to fully realize benefits to patients.

Deep Learning and Neural Networks: Decision-Making Implications

Editorial: Deep neural network based decision-making interpretability.

Augmenting Organizational Decision-Making with Deep Learning Algorithms: Principles, Promises, and Challenges

Relevance Inference Based on Direct Contribution: Counterfactual Explanation to Deep Networks for Intelligent Decision-making

From DDMs to DNNs: Using process data and models of decision-making to improve human-AI interactions

Deep Learning Algorithms and Multicriteria Decision-Making Used in Big Data: A Systematic Literature Review

Deep Reinforcement Learning and its Neuroscientific Implications

Model-Based Deep Learning: On the Intersection of Deep Learning and Optimization

Understanding of Machine Learning with Deep Learning: Architectures, Workflow, Applications and Future Directions

Evaluating deep neural networks in optimizing drug discovery and precision medicine: A review

Decision support from financial disclosures with deep neural networks and transfer learning

Deep Reinforcement Learning Unleashing the Power of AI in Decision-Making

Improving Decision Analytics with Deep Learning: The Case of Financial Disclosures

Frontiers of Deep Learning: From Novel Application to Real-World Deployment

Use of Neural Networks As Decision Makers in Strategic Situations

The Unreasonable Effectiveness of Deep Learning in Artificial Intelligence

Deep Learning: A Critical Appraisal

Applications of interpretable deep learning in neuroimaging: a comprehensive review